| Please register to receive the benefits of our network-wide features. |
Register (free) |
Log In
|
| Please register to receive the benefits of our network-wide features. |
Register (free) |
Log In
|
As part of the BayBIO series on personalized medicine, Dr. Moira Gunn speaks with Pierre Cassignol, President & CEO of XDX Expression Diagnostics. Cassignol talks about a major step forward in the long term treatment of transplant recipients.
On the Bio-Issue of the Week, David Ewing Duncan talks about his new biotech blog.
This program is from our Tech Nation series.
For The Conversations Network:
Play